Global Immunoprotein Diagnostic Testing Market

Immunoprotein Diagnostic Testing Market: Insights

Immunoproteins are proteins whose presence and functions are vital to the functions of the immune system of the human body. The immunoproteins in the body act as the main defense against the antigens attacking the body and by studying the immunoproteins, healthcare providers can better understand the ailment affecting the body and prescribe the ideal diagnosis to help the body fight against the disease. The immunoprotein diagnostic testing market has seen tremendous growth in the past few years, the growth has been driven by the increasing number of chronic and infectious diseases, the rising geriatric population globally, and the increasing demand for early diagnosis of chronic diseases. Technological advancements have increased the efficiency, accuracy, and speed of immunoprotein diagnostic testing. These advancements have increased the usage of immunoprotein diagnostic testing in diagnostic facilities, healthcare centers like hospitals and clinics, and research institutes. As per WHO, cardiovascular illnesses are the main source of death worldwide, 31% of all deaths in 2016. Cancer is the second leading cause of death in the world, WHO estimates that 1 in 6 deaths are due to cancer globally. Early diagnosis of cancer is proven to cut down the mortality rate as the patient responds better to medication and treatment quicker in the early stages. Immunoprotein diagnostic testing makes early detection possible and increases the survival rate of the patients. There are awareness movements to increase public awareness on chronic diseases which have also had an impact on the demand for immunoprotein diagnostic testing. With COVID-19 plaguing the world in the last year, immunoprotein diagnostic testing facilities manufacturers have had to cut down on production due to supply chain constraints while on the other hand, pharmaceutical companies released new immunoprotein diagnostic testing kits to detect the virus which has increased their demand. The market is constrained by stringent regulations on new immunoprotein testing procedures, the cost of implementation, and the inaccessibility of such diagnostic services to a large portion of the population, especially in developing nations.

Immunoprotein Diagnostic Testing Market: By Type

Based on the type of immunoprotein diagnostic testing, the market can be segmented as a pre-albumin diagnostic test, haptoglobin diagnostic test, immunoglobulin diagnostic test, free light chain diagnostic test, among other segments. The major shareholder of the market is the immunoglobulin diagnostic testing segment. Immunoglobulin diagnostic testing is widely used to study the immune system of the body and serves as one of the basic tests carried out to study the infection or disease afflicting the patient. The rising incidences of autoimmune diseases and infectious diseases have increased the demand for this segment in the immunoprotein diagnostic testing market.           

Immunoprotein Diagnostic Testing Market: By Application

Segmenting the immunoprotein diagnostic testing market based on the application, we have segments like autoimmune testing, infectious disease testing, allergy testing, oncology testing, among other segments. Infectious disease testing held the lion’s share of the market and is also expected to grow at a faster rate than the other segments during the forecast period. The rising incidences of infectious diseases like hepatitis, HIV, influenza, among others, are the major drivers of this segment in the immunoprotein diagnostic testing market.

Immunoprotein Diagnostic Testing Market: By Technology

Based on technology, the market is divided into radioimmunoassay, immunoturbidity assay, immunoprotein electrophoresis, enzyme-linked immunosorbent assay, and others. The enzyme-linked immunosorbent assay segment held the dominant share of the market over other segments during the forecast period. ELISA technology was invented in the early days of 1970was developed and since then has been greatly used to study the presence of antigens to detect the infection afflicting the body. It has been used to diagnose cancer, infectious diseases, and as a quality control measure by pharmaceutical companies. ELISA testing kits have a long shelf life and are relatively easier to use than other testing methods increasing their viability in the market.

Immunoprotein Diagnostic Testing Market: By Region

U.S., Canada, and Mexico will be the dominant countries as per the market value are concerned. The growing incidence of chronic diseases like cardiovascular diseases, cancer, and obesity combines with the rising geriatric population in the area has increased the demand for immunoprotein diagnostic testing in the region. The sophisticated and well-planned healthcare system in the region has made it easier for immunoprotein diagnostic testing vendors to penetrate the market in the region. The fastest-growing region is ought to be the Japan, China, India, and Rest of Asia Pacific countries in the market. The region has seen an increase in chronic diseases in recent years and the rising awareness of such diseases among the public in the region is expected to increase the demand for immunoprotein diagnostic testing in the region. The economic conditions of the countries in this region have made it harder for people to get access to such testing facilities which has increased the government spending on immunoprotein diagnostic testing kits to increase the availability of proper testing to all sections of society. The growing skilled labor force and increase in the number of immunoprotein diagnostic vendors in the region are expected to contribute to the growth of the market in this region.

Immunoprotein Diagnostic Testing Market: Share & Competitor Analysis

Abbott Laboratories, Diasorin, Fujirebio Diagnostics, AdnaGen, Abcam PLC, Bio-Rad Laboratories, Agilent Technologies, Eurobio Scientific, Menarini Diagnostics, Beckman Coulter, Enzo Life Sciences, Randox Laboratories,BioMerieux, Hoffmann-La Roche Diagnostics,Ortho-Clinical Diagnostics, F.,Adaltis, The Binding Site, Siemens Healthcare, Affymetrix and Thermo Fisher Scientific,among others,are the majorcompanies in the immunoprotein diagnostic testingmarket.

Please note: This is not an exhaustive list of companies profiled in the report.